Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""ANTITUBERCULAR agents"" wg kryterium: Temat


Tytuł:
Management of rifampicin-resistant tuberculosis in conflict-affected areas: The case of Iraq.
Autorzy:
Tesfahun HM; Médecins Sans Frontières (MSF), Operational Center Brussels, Brussels, Iraq.
Al-Salihi L; National TB Institute, Ministry of Health, Baghdad, Iraq.
Abdulkareem Al-Ani N; National TB Institute, Ministry of Health, Baghdad, Iraq.
Mankhi AA; National TB Institute, Ministry of Health, Baghdad, Iraq.
Mohammed A; MSF, Operational Center Brussels, Iraq Project, Baghdad, Iraq.
Lim CAE; MSF, Operational Center Brussels, Iraq Project, Baghdad, Iraq.
Al-Hilfi RA; Iraq Public Health Directorate, Baghdad, Iraq.
Jouego CG; Molecular Diagnostic and Research Group, University of Yaoundé I, Soa, Cameroon.
Decroo T; Institute of Tropical Medicine, Department of Clinical Sciences, Unit of HIV and Tuberculosis, Antwerp, Belgium.
Moussally K; MSF, Lebanon Branch Office, Middle East Medical Unit, Beirut, Lebanon.
Ferlazzo G; Southern African Medical Unit, Médecins Sans Frontiers, Cape Town, South Africa.
Isaakidis P; Southern African Medical Unit, Médecins Sans Frontiers, Cape Town, South Africa.; Clinical and Molecular Epidemiology Unit, Department of Hygiene and Epidemiology, University of loannina School of Medicine, loannina, Greece.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Jan 19; Vol. 19 (1), pp. e0296952. Date of Electronic Publication: 2024 Jan 19 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Antitubercular Agents*/therapeutic use
Tuberculosis, Multidrug-Resistant*/drug therapy
Humans ; Male ; Adolescent ; Rifampin/therapeutic use ; Retrospective Studies ; Iraq/epidemiology ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Predictors of multidrug-resistant tuberculosis in a teaching hospital in Ghana: A case-control study.
Autorzy:
Afful P; Department of Epidemiology and Biostatistics, Fred N. Binka School of Public Health, University of Health and Allied Sciences, Hohoe Campus, Hohoe, Ghana.; Public Health Unit, Cape Coast Teaching Hospital, Cape Coast, Ghana.
Vechey GA; Department of Epidemiology and Biostatistics, Fred N. Binka School of Public Health, University of Health and Allied Sciences, Hohoe Campus, Hohoe, Ghana.
Leta PK; Nkoranza South Municipal Health Directorate, Bono East Region, Nkoranza, Ghana.
Gbafu FB; Malaria Research Centre, Agogo, Ashanti Region, Ghana.
Aku FY; Department of Epidemiology and Biostatistics, Fred N. Binka School of Public Health, University of Health and Allied Sciences, Hohoe Campus, Hohoe, Ghana.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Nov 29; Vol. 18 (11), pp. e0294928. Date of Electronic Publication: 2023 Nov 29 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Antitubercular Agents*/therapeutic use
Tuberculosis, Multidrug-Resistant*/drug therapy
Tuberculosis, Multidrug-Resistant*/epidemiology
Tuberculosis, Multidrug-Resistant*/diagnosis
Humans ; Adult ; Middle Aged ; Case-Control Studies ; Ghana/epidemiology ; Risk Factors ; Hospitals, Teaching
Czasopismo naukowe
Tytuł:
Cost of digital technologies and family-observed DOT for a shorter MDR-TB regimen: a modelling study in Ethiopia, India and Uganda.
Autorzy:
Rosu L; Clinical Sciences Department, Liverpool School of Tropical Medicine, Liverpool, UK. .
Madan J; Warwick Medical School, University of Warwick, Coventry, UK.
Bronson G; Vital Strategies, New York, NY, USA.
Nidoi J; Makerere University Lung Institute, Kampala, Uganda.
Tefera MG; Addis Ababa Science and Technology University, Addis Ababa, Ethiopia.
Malaisamy M; National Institute for Research in Tuberculosis, Chennai, India.
Squire BS; Clinical Sciences Department, Liverpool School of Tropical Medicine, Liverpool, UK.
Worrall E; Liverpool School of Tropical Medicine, Vector Biology Department, Liverpool, UK.
Pokaż więcej
Źródło:
BMC health services research [BMC Health Serv Res] 2023 Nov 18; Vol. 23 (1), pp. 1275. Date of Electronic Publication: 2023 Nov 18.
Typ publikacji:
Journal Article
MeSH Terms:
Antitubercular Agents*/therapeutic use
Tuberculosis, Multidrug-Resistant*/drug therapy
Humans ; Ethiopia ; Digital Technology ; Uganda ; Directly Observed Therapy ; India
Czasopismo naukowe
Tytuł:
Systematic review and network meta-analysis of efficacy and safety of interventions for preventing anti-tuberculosis drug induced liver injury.
Autorzy:
Akkahadsee P; Master Degree of Clinical Pharmacy, Faculty of Pharmacy, Mahasarakham University, MahaSarakham, Thailand.
Sawangjit R; Clinical Trials and Evidence-Based Syntheses Research Unit (CTEBs RU), Mahasarakham University, MahaSarakham, Thailand. .
Phumart P; Department of Social and Administrative Pharmacy, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, Thailand.
Chaiyakunapruk N; Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA.; IDEAS Center, Veterans Affairs Salt Lake City Healthcare System, Salt Lake City, UT, USA.
Sakloetsakun D; Department of Pharmaceutical Technology, Faculty of Pharmaceutical Sciences, Khon Kaen University, Khon Kaen, Thailand.
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Nov 14; Vol. 13 (1), pp. 19880. Date of Electronic Publication: 2023 Nov 14.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antitubercular Agents*/adverse effects
Chemical and Drug Induced Liver Injury*/drug therapy
Chemical and Drug Induced Liver Injury*/etiology
Chemical and Drug Induced Liver Injury*/prevention & control
Humans ; Network Meta-Analysis
Czasopismo naukowe
Tytuł:
Efficacy of anti-tuberculosis drugs for the treatment of latent tuberculosis infection: a systematic review and network meta-analysis.
Autorzy:
Yoopetch P; Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand.
Anothaisintawee T; Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand.; Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Gunasekara ADM; Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand.; Department of Paraclinical Sciences, Faculty of Medicine, General Sir John Kotelawala Defence University, Ratmalana, Sri Lanka.
Jittikoon J; Department of Biochemistry, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.
Udomsinprasert W; Department of Biochemistry, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.
Thavorncharoensap M; Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand.; Social Administrative Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.
Youngkong S; Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand.; Social Administrative Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand.
Thakkinstian A; Department of Clinical Epidemiology and Biostatistics, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Chaikledkaew U; Mahidol University Health Technology Assessment (MUHTA) Graduate Program, Mahidol University, Bangkok, Thailand. .; Social Administrative Pharmacy Division, Department of Pharmacy, Faculty of Pharmacy, Mahidol University, Bangkok, Thailand. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Sep 27; Vol. 13 (1), pp. 16240. Date of Electronic Publication: 2023 Sep 27.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Antitubercular Agents*/adverse effects
Latent Tuberculosis*/drug therapy
Humans ; Isoniazid/adverse effects ; Network Meta-Analysis ; Drug Therapy, Combination
Czasopismo naukowe
Tytuł:
Under-reporting of adverse drug reactions: Surveillance system evaluation in Ho Municipality of the Volta Region, Ghana.
Autorzy:
Buabeng RO; Ghana Field Epidemiology and Laboratory Training Programme, Department of Epidemiology and Disease Control, School of Public Health, College of Health Sciences, University of Ghana, Accra, Ghana.
Dsane-Aidoo P; World Health Organization, Country Office, Accra, Ghana.
Asamoah YK; Ghana Field Epidemiology and Laboratory Training Programme, Department of Epidemiology and Disease Control, School of Public Health, College of Health Sciences, University of Ghana, Accra, Ghana.
Bandoh DA; Ghana Field Epidemiology and Laboratory Training Programme, Department of Epidemiology and Disease Control, School of Public Health, College of Health Sciences, University of Ghana, Accra, Ghana.
Boahen YA; Food and Drugs Authority, Accra, Ghana.
Sabblah GT; Food and Drugs Authority, Accra, Ghana.
Darko DM; Food and Drugs Authority, Accra, Ghana.
Lwanga CN; Ghana Field Epidemiology and Laboratory Training Programme, Department of Epidemiology and Disease Control, School of Public Health, College of Health Sciences, University of Ghana, Accra, Ghana.
Ameme DK; Ghana Field Epidemiology and Laboratory Training Programme, Department of Epidemiology and Disease Control, School of Public Health, College of Health Sciences, University of Ghana, Accra, Ghana.
Kenu E; Ghana Field Epidemiology and Laboratory Training Programme, Department of Epidemiology and Disease Control, School of Public Health, College of Health Sciences, University of Ghana, Accra, Ghana.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Sep 12; Vol. 18 (9), pp. e0291482. Date of Electronic Publication: 2023 Sep 12 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Antitubercular Agents*
Drug-Related Side Effects and Adverse Reactions*/epidemiology
Humans ; Female ; Ghana/epidemiology ; Checklist ; Data Accuracy ; Databases, Factual
Czasopismo naukowe
Tytuł:
Evaluation of Acute and Sub-Acute Toxicity, Oxidative Stress and Molecular Docking of Two Nitrofuranyl Amides as Promising Anti-Tuberculosis Agents.
Autorzy:
Dimitrov S; The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
Slavchev I; Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
Simeonova R; Department of Pharmacology, Pharmacotherapy, and Toxicology, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.
Mileva M; The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
Pencheva T; Institute of Biophysics and Biomedical Engineering, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
Philipov S; Department of Human Anatomy, Histology, General and Clinical Pathology and Forensic Medicine, Faculty of Medicine, Sofia University 'St. Kliment Ohridski', 1407 Sofia, Bulgaria.
Georgieva A; The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.; Institute of Neurobiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
Tsvetanova E; The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.; Institute of Neurobiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
Teneva Y; Department of Pharmacology, Pharmacotherapy, and Toxicology, Faculty of Pharmacy, Medical University of Sofia, 1000 Sofia, Bulgaria.
Rimpova N; Department of Paediatrics, University Children's Hospital, Medical University of Sofia, 1431 Sofia, Bulgaria.
Dobrikov G; Institute of Organic Chemistry with Centre of Phytochemistry, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
Valcheva V; The Stephan Angeloff Institute of Microbiology, Bulgarian Academy of Sciences, 1113 Sofia, Bulgaria.
Pokaż więcej
Źródło:
Biomolecules [Biomolecules] 2023 Jul 28; Vol. 13 (8). Date of Electronic Publication: 2023 Jul 28.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antitubercular Agents*/toxicity
Amides*/pharmacology
Animals ; Mice ; Molecular Docking Simulation ; Eye ; Oxidative Stress
Czasopismo naukowe
Tytuł:
[DRESS syndrome induced by anti-TB drugs].
Autorzy:
Pavón-Romero GF; Departamento de Inmunogenética y Alergia, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Ciudad de México.
Parra-Vargas MI; Departamento de Inmunogenética y Alergia, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Ciudad de México.
Rosas-Fernández R; Servicio de Pediatría, Hospital General de Playa del Carmen 18, Instituto Mexicano del Seguro Social, Quintana Roo, México.
Ramírez-Jiménez F; Departamento de Inmunogenética y Alergia, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Ciudad de México.
Gutiérrez-Quiroz KV; Departamento de Inmunogenética y Alergia, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Ciudad de México.
Terán LM; Departamento de Inmunogenética y Alergia, Instituto Nacional de Enfermedades Respiratorias Ismael Cosío Villegas, Ciudad de México. .
Pokaż więcej
Transliterated Title:
Síndrome de DRESS inducido por fármacos antituberculosos.
Źródło:
Revista alergia Mexico (Tecamachalco, Puebla, Mexico : 1993) [Rev Alerg Mex] 2023 Jun 28; Vol. 70 (2), pp. 55-63. Date of Electronic Publication: 2023 Jun 28.
Typ publikacji:
English Abstract; Journal Article
MeSH Terms:
Antitubercular Agents*/adverse effects
Drug Hypersensitivity Syndrome*/etiology
Eosinophilia*/chemically induced
Humans ; Adrenal Cortex Hormones/therapeutic use ; Eosinophils
Czasopismo naukowe
Tytuł:
Factors associated with the unsuccessful TB treatment outcomes in the northern regions of Namibia: a mixed methods study.
Autorzy:
Amkongo M; Department of Radiography, School of Allied Health Sciences, University of Namibia, P.O Box 3728, Windhoek, Namibia. .
Mitonga HK; Public Health Department, School of Nursing and Public Health, University of Namibia, Windhoek, Namibia.
Alfeus A; Public Health Department, School of Nursing and Public Health, University of Namibia, Windhoek, Namibia.
Shipingana LNN; Department of Human, Biological & Translational Medical Sciences, School of Medicine, University of Namibia, Windhoek, Namibia.
Keendjele T; Department of Human, Biological & Translational Medical Sciences, School of Medicine, University of Namibia, Windhoek, Namibia.
Eelu H; Department of Human, Biological & Translational Medical Sciences, School of Medicine, University of Namibia, Windhoek, Namibia.
Nashihanga T; Department of Human, Biological & Translational Medical Sciences, School of Medicine, University of Namibia, Windhoek, Namibia.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2023 May 22; Vol. 23 (1), pp. 342. Date of Electronic Publication: 2023 May 22.
Typ publikacji:
Journal Article
MeSH Terms:
Antitubercular Agents*/therapeutic use
Tuberculosis, Miliary*
Adult ; Humans ; Young Adult ; Middle Aged ; Namibia/epidemiology ; Treatment Outcome ; Risk Factors
Czasopismo naukowe
Tytuł:
Comparing adherence to MDR-TB treatment among patients on self-administered therapy and those on directly observed therapy: non-inferiority randomized controlled trial.
Autorzy:
Wekesa C; Infectious Diseases Institute, Makerere University, Kampala, Uganda. .
Sekaggya-Wiltshire C; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
Muyanja SZ; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
Lume I; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
Nabaggala MS; Infectious Diseases Institute, Makerere University, Kampala, Uganda.
Parkes-Ratanshi R; Infectious Diseases Institute, Makerere University, Kampala, Uganda.; Department of Public Health, Cambridge University, Cambridge, UK.
Akello SA; TB unit, Mulago National Referral Hospital, Kampala, Uganda.
Pokaż więcej
Źródło:
Trials [Trials] 2023 May 12; Vol. 24 (1), pp. 326. Date of Electronic Publication: 2023 May 12.
Typ publikacji:
Randomized Controlled Trial; Journal Article
MeSH Terms:
Antitubercular Agents*/adverse effects
Tuberculosis, Multidrug-Resistant*/diagnosis
Tuberculosis, Multidrug-Resistant*/drug therapy
Humans ; Directly Observed Therapy ; Treatment Outcome ; Clinical Protocols ; Medication Adherence
Czasopismo naukowe
Tytuł:
Definitive outcomes in patients with rifampicin-resistant tuberculosis treated in Niger from 2012 to 2019: A retrospective cohort study.
Autorzy:
Souleymane MB; Damien Foun dation Niger, TB-MR, BP: 1065 Niamey, Niger.
Decroo T; Institute of Tropical Medicine, Unit of Mycobacteriology, Nationalestraat 155, 2000 Antwerp, Belgium.; Research Foundation Flanders, 1000 Brussels, Belgium.
Mamadou S; Université Abdou Moumouni de Niamey, Faculté des Sciences de la Santé, BP: 237 Niamey, Niger.
Soumana A; Programme National de Lutte contre la Tuberculose, Coordination, BP: 613 Niamey, Niger.
Lawan IM; Damien Foun dation Niger, TB-MR, BP: 1065 Niamey, Niger.
Gagara-Issoufou A; Université Abdou Moumouni de Niamey, Faculté des Sciences de la Santé, BP: 237 Niamey, Niger.
Adehossi E; Université Abdou Moumouni de Niamey, Faculté des Sciences de la Santé, BP: 237 Niamey, Niger.
Ortuño-Gutiérrez N; Damien Foundation Brussels, TB-MR, Boulevard Léopold II 263, 1081 Brussels, Belgium.
Lynen L; Institute of Tropical Medicine, Unit of Mycobacteriology, Nationalestraat 155, 2000 Antwerp, Belgium.
Rigouts L; Institute of Tropical Medicine, Unit of Mycobacteriology, Nationalestraat 155, 2000 Antwerp, Belgium.; University of Antwerp, Biomedical Sciences, Prinsstraat 13, 2000 Antwerp, Belgium.
de Jong BC; Institute of Tropical Medicine, Unit of Mycobacteriology, Nationalestraat 155, 2000 Antwerp, Belgium.
Van Deun A; Independent Consultant, 3000 Leuven, Belgium.
Piubello A; Damien Foun dation Niger, TB-MR, BP: 1065 Niamey, Niger.; Damien Foundation Brussels, TB-MR, Boulevard Léopold II 263, 1081 Brussels, Belgium.
Pokaż więcej
Źródło:
International health [Int Health] 2023 May 02; Vol. 15 (3), pp. 258-264.
Typ publikacji:
Journal Article
MeSH Terms:
Antitubercular Agents*/therapeutic use
Tuberculosis, Multidrug-Resistant*/drug therapy
Humans ; Rifampin/therapeutic use ; Retrospective Studies ; Niger ; Treatment Outcome ; Fluoroquinolones/pharmacology ; Fluoroquinolones/therapeutic use
Czasopismo naukowe
Tytuł:
The clinical profile and outcomes of drug resistant tuberculosis in Central Province of Zambia.
Autorzy:
Chanda E; Department of Public Health, Texila American University, Lusaka, Zambia. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Apr 01; Vol. 24 (1), pp. 364. Date of Electronic Publication: 2024 Apr 01.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Mycobacterium tuberculosis*
Tuberculosis, Multidrug-Resistant*/drug therapy
Tuberculosis, Multidrug-Resistant*/epidemiology
Adult ; Humans ; Male ; Middle Aged ; Antitubercular Agents/pharmacology ; Antitubercular Agents/therapeutic use ; Cross-Sectional Studies ; Prevalence ; Recurrence ; Retrospective Studies ; Zambia/epidemiology ; Female
Czasopismo naukowe
Tytuł:
The exceptions that prove the rule-a historical view of bedaquiline susceptibility.
Autorzy:
Miotto P; Emerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Cirillo DM; Emerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Schön T; Department of Infectious Diseases, Region Östergötland, Linköping University Hospital, Linköping, Sweden.; Division of Infection and Inflammation, Institute of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.; Department of Infectious Diseases, Kalmar County Hospital, Linköping University, Kalmar, Sweden.
Köser CU; Department of Genetics, University of Cambridge, Cambridge, UK. .
Pokaż więcej
Źródło:
Genome medicine [Genome Med] 2024 Mar 13; Vol. 16 (1), pp. 39. Date of Electronic Publication: 2024 Mar 13.
Typ publikacji:
Journal Article
MeSH Terms:
Diarylquinolines*/pharmacology
Mycobacterium tuberculosis*/genetics
Humans ; Antitubercular Agents/pharmacology ; Antitubercular Agents/therapeutic use ; Mutation
Czasopismo naukowe
Tytuł:
Detection of a historic reservoir of bedaquiline/clofazimine resistance-associated variants in Mycobacterium tuberculosis.
Autorzy:
Nimmo C; UCL Genetics Institute, University College London, Darwin Building, Gower Street, London, UK. .; Division of Infection and Immunity, University College London, London, UK. .; Africa Health Research Institute, Durban, South Africa. .
Ortiz AT; UCL Genetics Institute, University College London, Darwin Building, Gower Street, London, UK.; Department of Medicine, Imperial College, London, UK.
Tan CCS; UCL Genetics Institute, University College London, Darwin Building, Gower Street, London, UK.
Pang J; UCL Genetics Institute, University College London, Darwin Building, Gower Street, London, UK.; Division of Infection and Immunity, University College London, London, UK.
Acman M; UCL Genetics Institute, University College London, Darwin Building, Gower Street, London, UK.
Millard J; Africa Health Research Institute, Durban, South Africa.; Wellcome Trust Liverpool Glasgow Centre for Global Health Research, Liverpool, UK.; Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.
Padayatchi N; CAPRISA MRC-HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa.
Grant AD; Africa Health Research Institute, Durban, South Africa.; TB Centre, London School of Hygiene & Tropical Medicine, London, UK.
O'Donnell M; CAPRISA MRC-HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa.; Department of Medicine & Epidemiology, Columbia University Irving Medical Center, New York, NY, USA.
Pym A; Africa Health Research Institute, Durban, South Africa.
Brynildsrud OB; Division of Infectious Diseases and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.
Eldholm V; Division of Infectious Diseases and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.
Grandjean L; Division of Infection and Immunity, University College London, London, UK.; Laboratorio de Investigacion y Enfermedades Infecciosas, Universidad Peruana Cayetano Heredia, Lima, Peru.; Department of Infection, Immunity and Inflammation, Institute of Child Health, University College London, London, UK.
Didelot X; School of Life Sciences and Department of Statistics, University of Warwick, Coventry, UK.
Balloux F; UCL Genetics Institute, University College London, Darwin Building, Gower Street, London, UK. .
van Dorp L; UCL Genetics Institute, University College London, Darwin Building, Gower Street, London, UK. .
Pokaż więcej
Źródło:
Genome medicine [Genome Med] 2024 Feb 19; Vol. 16 (1), pp. 34. Date of Electronic Publication: 2024 Feb 19.
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*/genetics
Tuberculosis*/drug therapy
Diarylquinolines*
Humans ; Clofazimine ; Antitubercular Agents/pharmacology ; Antitubercular Agents/therapeutic use ; Microbial Sensitivity Tests ; Phylogeny
Czasopismo naukowe
Tytuł:
Determinants of drug-resistant tuberculosis in Hunan province, China: a case-control study.
Autorzy:
Akalu TY; School of Population Health, Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia. .; Geospatial and Tuberculosis Research Team, Telethon Kids Institute, Perth, Western Australia, Australia. .; Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. .
Clements ACA; Geospatial and Tuberculosis Research Team, Telethon Kids Institute, Perth, Western Australia, Australia.; Penninsula Medical School, University of Plymouth, Plymouth, UK.
Xu Z; Xiangya School of Public Health, Central South University, Changsha, China.
Bai L; TB Control Institute of Hunan Province, Changsha, China.
Alene KA; School of Population Health, Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia.; Geospatial and Tuberculosis Research Team, Telethon Kids Institute, Perth, Western Australia, Australia.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Feb 13; Vol. 24 (1), pp. 198. Date of Electronic Publication: 2024 Feb 13.
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*
Tuberculosis, Multidrug-Resistant*/drug therapy
Tuberculosis, Multidrug-Resistant*/epidemiology
Tuberculosis, Multidrug-Resistant*/complications
Humans ; Adult ; Adolescent ; Young Adult ; Middle Aged ; Case-Control Studies ; Microbial Sensitivity Tests ; China/epidemiology ; Antitubercular Agents/pharmacology ; Antitubercular Agents/therapeutic use
Czasopismo naukowe
Tytuł:
TB-DROP: deep learning-based drug resistance prediction of Mycobacterium tuberculosis utilizing whole genome mutations.
Autorzy:
Wang Y; Center of Growth, Metabolism and Aging, Key Laboratory of Bio-Resources and Eco-Environment of the Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, 610064, China.
Jiang Z; Key Laboratory of Bio-Resources and Eco-Environment of the Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, 610064, China.
Liang P; Key Laboratory of Bio-Resources and Eco-Environment of the Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, 610064, China.; Zhejiang Yangshengtang Institute of Natural Medication Co., Ltd, Hangzhou, China.
Liu Z; Key Laboratory of Bio-Resources and Eco-Environment of the Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, 610064, China.
Cai H; Center of Growth, Metabolism and Aging, Key Laboratory of Bio-Resources and Eco-Environment of the Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, 610064, China. .
Sun Q; Key Laboratory of Bio-Resources and Eco-Environment of the Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, 610064, China. .
Pokaż więcej
Źródło:
BMC genomics [BMC Genomics] 2024 Feb 12; Vol. 25 (1), pp. 167. Date of Electronic Publication: 2024 Feb 12.
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*/genetics
Deep Learning*
Tuberculosis*/microbiology
Tuberculosis, Multidrug-Resistant*/drug therapy
Humans ; Antitubercular Agents/pharmacology ; Antitubercular Agents/therapeutic use ; Mutation ; Microbial Sensitivity Tests
Czasopismo naukowe
Tytuł:
Metabolites from Streptomyces aureus (VTCC43181) and Their Inhibition of Mycobacterium tuberculosis ClpC1 Protein.
Autorzy:
Tran TTP; Institute of Chemistry, Vietnam Academy of Science and Technology (VAST),18 Hoang Quoc Viet Road, Cau Giay, Hanoi 10000, Vietnam.; Faculty of Chemistry, Graduate University of Science and Technology, VAST, 18 Hoang Quoc Viet Road, Cau Giay, Hanoi 10000, Vietnam.
Huynh NNT; Faculty of Chemistry, Graduate University of Science and Technology, VAST, 18 Hoang Quoc Viet Road, Cau Giay, Hanoi 10000, Vietnam.; Faculty of Natural Sciences, Phu Yen University, 01 Nguyen Van Huyen Road, Tuy Hoa City 56000, Vietnam.
Pham NT; Institute of Chemistry, Vietnam Academy of Science and Technology (VAST),18 Hoang Quoc Viet Road, Cau Giay, Hanoi 10000, Vietnam.
Nguyen DT; Institute of Chemistry, Vietnam Academy of Science and Technology (VAST),18 Hoang Quoc Viet Road, Cau Giay, Hanoi 10000, Vietnam.
Tran CV; Institute of Chemistry, Vietnam Academy of Science and Technology (VAST),18 Hoang Quoc Viet Road, Cau Giay, Hanoi 10000, Vietnam.
Nguyen UQ; Institute of Microbiology and Biotechnology, Vietnam National University Hanoi, 44, Xuan Thuy Road, Cau Giay, Hanoi 10000, Vietnam.
Ho AN; Institute of Biotechnology, Vietnam Academy of Science and Technology (VAST), 18 Hoang Quoc Viet Road, Cau Giay, Hanoi 10000, Vietnam.
Suh JW; Center for Nutraceutical and Pharmaceutical Materials, Myongji University, Yongin 17058, Republic of Korea.
Cheng J; Center for Nutraceutical and Pharmaceutical Materials, Myongji University, Yongin 17058, Republic of Korea.
Nguyen TKN; Faculty of Biology, University of Natural Sciences, Vietnam National University, Hanoi, 334 Nguyen Trai Road, Thanh Xuân, Hanoi 10000, Vietnam.
Tran SV; Institute of Chemistry, Vietnam Academy of Science and Technology (VAST),18 Hoang Quoc Viet Road, Cau Giay, Hanoi 10000, Vietnam.; Faculty of Chemistry, Graduate University of Science and Technology, VAST, 18 Hoang Quoc Viet Road, Cau Giay, Hanoi 10000, Vietnam.
Nguyen DM; Institute of Genome Research, Vietnam Academy of Science and Technology (VAST), 18 Hoang Quoc Viet Road, Cau Giay, Hanoi 10000, Vietnam.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2024 Feb 04; Vol. 29 (3). Date of Electronic Publication: 2024 Feb 04.
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*
Streptomyces*
Staphylococcus aureus/metabolism ; Antitubercular Agents/pharmacology ; Antitubercular Agents/metabolism ; Bacterial Proteins/chemistry ; Adenosine Triphosphatases/metabolism
SCR Organism:
Streptomyces aureus
Czasopismo naukowe
Tytuł:
Direct capture, inhibition and crystal structure of HsaD (Rv3569c) from M. tuberculosis.
Autorzy:
Barelier S; CNRS, AFMB, Aix-Marseille University, France.
Avellan R; CNRS, LISM, IMM FR3479, Aix-Marseille University, France.
Gnawali GR; Department of Chemistry and Biochemistry, University of Missouri-St. Louis, MO, USA.
Fourquet P; INSERM, CNRS, Institut Paoli-Calmettes, CRCM, Marseille Protéomique, Aix-Marseille University, France.
Roig-Zamboni V; CNRS, AFMB, Aix-Marseille University, France.
Poncin I; CNRS, LISM, IMM FR3479, Aix-Marseille University, France.
Point V; CNRS, LISM, IMM FR3479, Aix-Marseille University, France.
Bourne Y; CNRS, AFMB, Aix-Marseille University, France.
Audebert S; INSERM, CNRS, Institut Paoli-Calmettes, CRCM, Marseille Protéomique, Aix-Marseille University, France.
Camoin L; INSERM, CNRS, Institut Paoli-Calmettes, CRCM, Marseille Protéomique, Aix-Marseille University, France.
Spilling CD; Department of Chemistry and Biochemistry, University of Missouri-St. Louis, MO, USA.
Canaan S; CNRS, LISM, IMM FR3479, Aix-Marseille University, France.
Cavalier JF; CNRS, LISM, IMM FR3479, Aix-Marseille University, France.
Sulzenbacher G; CNRS, AFMB, Aix-Marseille University, France.
Pokaż więcej
Źródło:
The FEBS journal [FEBS J] 2023 Mar; Vol. 290 (6), pp. 1563-1582. Date of Electronic Publication: 2022 Oct 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Antitubercular Agents*/chemical synthesis
Antitubercular Agents*/pharmacology
Antitubercular Agents*/therapeutic use
Mycobacterium tuberculosis*/drug effects
Mycobacterium tuberculosis*/enzymology
Bacterial Proteins*/antagonists & inhibitors
Bacterial Proteins*/chemistry
Organophosphorus Compounds*/chemistry
Hydrolases*/antagonists & inhibitors
Hydrolases*/chemistry
Molecular Docking Simulation*
Humans ; Macrophages/microbiology ; Tuberculosis/drug therapy ; Crystallography, X-Ray ; Computer Simulation
Czasopismo naukowe
Tytuł:
Cost-consequence analysis of ambulatory clinic- and home-based multidrug-resistant tuberculosis management models in Eswatini.
Autorzy:
Peresu E; Centre for Development Support, Faculty of Economic and Management Sciences, University of the Free State, Bloemfontein, South Africa.
De Graeve D; Faculty of Business and Economics, University of Antwerp, Antwerp, Belgium.
Heunis JC; Centre for Health Systems Research & Development, University of the Free State, Bloemfontein, South Africa.
Kigozi NG; Centre for Health Systems Research & Development, University of the Free State, Bloemfontein, South Africa.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2024 Apr 02; Vol. 19 (4), pp. e0301507. Date of Electronic Publication: 2024 Apr 02 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Tuberculosis, Multidrug-Resistant*/drug therapy
Home Care Services*
Humans ; Eswatini ; Cost-Benefit Analysis ; Ambulatory Care ; Antitubercular Agents/therapeutic use ; Health Care Costs
Czasopismo naukowe
Tytuł:
Identification of Novel Antimicrobial Compounds Targeting Mycobacterium tuberculosis S -Adenosyl-L-Homocysteine Hydrolase Using Dual Hierarchical In Silico Structure-Based Drug Screening.
Autorzy:
Ito H; Department of Bioscience and Bioinformatics, Graduate School of Computer Science and Systems Engineering, Kyushu Institute of Technology, Iizuka 820-8502, Japan.
Monobe K; Department of Bioscience and Bioinformatics, Graduate School of Computer Science and Systems Engineering, Kyushu Institute of Technology, Iizuka 820-8502, Japan.
Okubo S; Department of Bioscience and Bioinformatics, Graduate School of Computer Science and Systems Engineering, Kyushu Institute of Technology, Iizuka 820-8502, Japan.
Aoki S; Department of Bioscience and Bioinformatics, Graduate School of Computer Science and Systems Engineering, Kyushu Institute of Technology, Iizuka 820-8502, Japan.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2024 Mar 14; Vol. 29 (6). Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*
Tuberculosis*/microbiology
Humans ; Antitubercular Agents/chemistry ; Drug Evaluation, Preclinical ; Homocysteine/pharmacology ; Hydrolases/pharmacology ; Molecular Docking Simulation
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies